相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyclic neutropenia in animals
Jorge M. Pacheco et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
Susanne Schnittger et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
The complete evaluation of erythrocytosis: congenital and acquired
M. M. Patnaik et al.
LEUKEMIA (2009)
Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations
Sai Li et al.
BLOOD (2008)
Loss of the JAK2 intramolecular auto-inhibition mechanism is predicted by structural modelling of a novel exon 12 insertion mutation in a case of idiopathic erythrocytosis
Elena Albiero et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients
Eirini Kouroupi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science
O. Kilpivaara et al.
LEUKEMIA (2008)
JAK and MPL mutations in myeloid malignancies
Ayalew Tefferi
LEUKEMIA & LYMPHOMA (2008)
JAK2 exon 12 mutation in JAK2V617F-negative polycythemia vera
Benno Rothlisberger et al.
LEUKEMIA & LYMPHOMA (2008)
Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders
Daniela Pietra et al.
BLOOD (2008)
Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients
C. M. Butcher et al.
LEUKEMIA (2008)
JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis
Luz Martinez-Aviles et al.
HAEMATOLOGICA (2007)
The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels
Melanie J. Percy et al.
HAEMATOLOGICA (2007)
Phenotypic variations and new mutations in JAK2 V617F-neagative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis
Donna M. Williams et al.
EXPERIMENTAL HEMATOLOGY (2007)
JAK2 mutations and clinical practice in myeloproliferative neoplasms
Ayalew Tefferi
CANCER JOURNAL (2007)
Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera
Linda M. Scott et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera
A. Pardanani et al.
LEUKEMIA (2007)
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelotibrosis: recommendations from an ad hoc international expert panel
Ayalew Tefferi et al.
BLOOD (2007)
Clinical correlates of JAK2V617F allele burden in essential thrombocythemia
Jaya Kittur et al.
CANCER (2007)
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis
Linda M. Scott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Oncogenes in myeloproliferative disorders
Ayalew Tefferi et al.
CELL CYCLE (2007)
Classification of Ph-negative chronic myeloproliferative disorders - Morphology as the yardstick of classification
Hans Michael Kvasnicka et al.
PATHOBIOLOGY (2007)
JAK2 V617F in myeloid disorders: What do we know now, and where are we headed?
ME Nelson et al.
LEUKEMIA & LYMPHOMA (2006)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
分享论文
